Our Researchers in Action

Phase I Trial of Folate Receptor-Alpha CAR T-Cell Therapy for Solid Cancer
At the University of Pennsylvania Perelman School of Medicine (Philadelphia, PA), Daniel J. Powell, Jr., PhD, and colleagues are offering new hope to women battling advanced ovarian cancer. With a novel CAR T immunotherapy strategy, Dr. Powell uses genetic engineering to engage a patient’s existing immune system and enable it to recognize and destroy cancer.